News & Events IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW MANAGEMENT BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW MANAGEMENT BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR News & Events Press Releases Sep 28, 2023 Ardelyx Announces Publication of Positive Results from T3MPO-3 Long-Term Open-Label Safety Trial of Tenapanor for IBS-C in the Journal of Neurogastroenterology and Motility Read More Sep 25, 2023 Tenapanor for Hyperphosphatemia Approved in Japan Read More Sep 11, 2023 Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023 Read More View All Press Releases Events & Presentations Sep 11, 2023 at 12:00 PM EDT H.C. Wainwright 25th Annual Global Investment Conference Aug 2, 2023 at 8:00 AM EDT Ardelyx Q2 2023 Earnings Call Jul 25, 2023 at 2:00 PM EDT H.C. Wainwright 2nd Annual Kidney Conference View All Events FAQs Email Alerts Connect
News & Events Press Releases Sep 28, 2023 Ardelyx Announces Publication of Positive Results from T3MPO-3 Long-Term Open-Label Safety Trial of Tenapanor for IBS-C in the Journal of Neurogastroenterology and Motility Read More Sep 25, 2023 Tenapanor for Hyperphosphatemia Approved in Japan Read More Sep 11, 2023 Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023 Read More View All Press Releases Events & Presentations Sep 11, 2023 at 12:00 PM EDT H.C. Wainwright 25th Annual Global Investment Conference Aug 2, 2023 at 8:00 AM EDT Ardelyx Q2 2023 Earnings Call Jul 25, 2023 at 2:00 PM EDT H.C. Wainwright 2nd Annual Kidney Conference View All Events
Sep 28, 2023 Ardelyx Announces Publication of Positive Results from T3MPO-3 Long-Term Open-Label Safety Trial of Tenapanor for IBS-C in the Journal of Neurogastroenterology and Motility Read More
Sep 11, 2023 Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023 Read More